➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Express Scripts
Colorcon

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

FLEXBUMIN Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: FLEXBUMIN
Recent Litigation for FLEXBUMIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Samsung Bioepis Co. Ltd.2020-06-28
ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD.2019-08-08
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all FLEXBUMIN litigation

PTAB Litigation
PetitionerDate
Apotex Inc.2017-11-09
Cipla Ltd.2017-11-09
Actavis LLC2017-04-04

See all FLEXBUMIN litigation

Patent Text Search: US Patents for FLEXBUMIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for FLEXBUMIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
563 Finland   Try Before You Buy
C300691 Netherlands   Try Before You Buy PRODUCT NAME: ALBUMINE-FUSIE-EIWIT MET GLUCAGONACHTIG-PEPTIDE 1 (GLP-1)-ACTIVITEIT, OMVATTENDE TWEE TANDEMSGEWIJS GEORIENTEERDE AAN ALBUMINE GEFUSEERDE GLP-1-POLYPEPTIDEN, ZOALS GESPECIFICEERD IN DELEN (I) EN (II) VAN CONCLUSIE 1 VAN EP1463751; ZOALS EEN ALBUMINE-FUSIE-EIWIT MET GLUCAGONACHTIG-PEPTIDE 1 (GLP-1)-ACTIVITEIT, OMVATTENDE TWEE TANDEMSGEWIJS GEORIENTEERDE AAN ALBUMINE GEFUSEERDE GLP-1 (7-36(A8G))-POLYPEPTIDEN, ZOALS EEN ALBUMINE-FUSIE-EIWIT MET GLUCAGONACHTIG-PEPTIDE 1 (GLP-1)-ACTIVITEIT, OMVATTENDE TWEE TANDEMSGEWIJS GEORIENTEERDE AAN HUMAAN SERUM ALBUMINE GEFUSEERDE GLP-1)7-36(A8G))-POLYPEPTIDEN, ZOALS EEN ALBUMIDEFUSIE MET GLUCAGONACHTIG-PEPTIDE 1 (GLP-1)-ACTIVITEIT, OMVATTENDE
132014902293932 Italy   Try Before You Buy PRODUCT NAME: ALBIGLUTIDE(EPERZAN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/908, 20140321
2014C/037 Belgium   Try Before You Buy PRODUCT NAME: PACLITAXEL DANS UNE FORMULATION DE NANOPARTICULE LIEES A L'ALBUMINE; AUTHORISATION NUMBER AND DATE: EU/1/07/428 20131230
PA2014022 Lithuania   Try Before You Buy PRODUCT NAME: PACLITAXELUM; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Johnson and Johnson
Mallinckrodt
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.